Proteomics techniques and their application to hematology

Blood

Volumn 103, Issue 10, 2004, Pages 3624-3634

  Cristea, Ileana M ^b   Gaskell, Simon J ^b   Whetton, Anthony D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; GENE SEQUENCE; GENOMICS; HEMATOLOGY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TRANSLATION REGULATION;

EID: 2342541676     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-09-3295     Document Type: Review

References (99)

1. Han KK, Martinage A. Post-translational chemical modification(s) of proteins. Int J Biochem. 1992; 24:19-28.
2. Voehringer DW, Hirschberg DL, Xiao J, et al. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc Natl Acad Sci U S A. 2000;;97:2680-2695.
3. Blohm DH, Guiseppi-Elle A. New developments In microarray technology. Curr Opin Biotechnol. 2001;12:41-47.
4. Futcher B, Latter GI, Monardo P, McLaughlin CS, Garrels JI. A sampling of the yeast proteome. Mol Cell Biol. 1999;19:7357-7368.
5. Gygl SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol. 1999;19:1720-1730.
6. Lian Z, Kluger Y, Greenbaum DS, et al. Genomic and proteomic analysis of the myeloid differentiation program: global analysis of gene expression during induced differentiation in the MPRO cell line. Blood. 2002;100:3209-3220.
7. Dreger M. Proteome analysis at the level of subcellular structures. Eur J Biochem. 2003;270:569-599.
8. Huber LA, Pfaller K, Vietor I. Organelle proteomics: implications for subcellular fractionation in proteomics. Circ Res. 2003;92:962-966.
9. Gorg A, Obermaier C, Boguth G, et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis. 2000; 21:1037-1053.
10. Patton WF. Detection technologies In proteome analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;771:3-31.
11. Berggren K, Steinberg TH, Lauber WM, et al. A luminescent ruthenium complex for ultrasensitive detection of proteins immobilized on membrane supports. Anal Biochem. 1999;276:129-143.
12. Tonge R, Shaw J, Middleton B, et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics. 2001;1:377-396.
13. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999;17:994-999.
14. Cochran DAE, Evans CA, Blinco D, et al. Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig VH genes. Mol Cell Proteomics. 2004;2:1331-1341.
15. Hoving S, Voshol H, van Oostrum J. Towards high performance two-dimensional gel electrophoresis using ultrazoom gels. Electrophoresis. 2000;21:2617-2621.
16. Adkins JN, Vamum SM, Auberry KJ, et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics. 2002;1947-955.
17. Stulik J, Tichy M, Kovarova H. Two-dimensional gel electrophoresis of four serum samples from patients with IgD myeloma. Clin Chim Acta. 1993; 218:149-158.
18. Skibeli V, Nissen-Lie G, Torjesen P. Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood. 2001;98:3626-3634.
19. Csar XF, Wilson NJ, Strike P, et al. Copper/zinc superoxide dismutase is phosphorylated and modulated specifically by granulocyte-colony stimulating factor in myeloid cells. Proteomics. 2001;1:435-443.
20. Lewis TS, Hunt JB, Aveline LD, et al. Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry. Mol Cell. 2000;6:1343-1354.
21. Martin K, Steinberg TH, Cooley LA, Gee KR, Beechem JM, Patton WF. Quantitative analysis of protein phosphorylation status and protein kinase activity on microarrays using a novel fluorescent phosphorylation sensor dye. Proteomics. 2003;3: 1244-1255.
22. Blagoev B, Kratchmarova I, Ong SE, Nielsen M, Foster LJ, Mann M. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol. 2003;21: 315-316.
23. van Anken E, Romijn EP, Maggioni C, et al. Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion. Immunity. 2003;16:243-253.
24. Hanash SM, Madoz-Gurpide J, Misek DE. Identification of novel targets for cancer therapy using expression proteomics. Leukemia. 2002;16:476-485.
25. Antonucci F, Chilosi M, Santacatterina M, Herbert B, Righetti PG. Proteomics and immunomapping of reactive lymph-node and lymphoma. Electrophoresis. 2002;23:356-362.
26. Wang HX, Ma XC, Deng QL, Li D. Cytotoxicity of flutamide and 2-hydroxyflutamide and their effects on CYP1A2 mRNA in primary rat hepatocytes. Acta Pharmacol Sin. 2002;23:562-566.
27. Levi-Schaffer F, Temkin V, Simon HU, Kettman JR, Frey JR, Lefkovits I. Proteomic analysis of human eosinophil activation mediated by mast cells, granulocyte macrophage colony stimulating factor and tumor necrosis factor alpha. Proteomics. 2002;2:1616-1626.
28. Bell AW, Ward MA, Blackstock WP, et al. Proteomics characterization of abundant Golgi membrone brane proteins. J Biol Chem. 2001;276:5152-5165.
29. Andersen JS, Lyon CE, Fox AH, et al. Directed proteomic analysis of the human nucleolus. Curr Biol. 2002;12:1-11.
30. Garin J, Diez R, Kieffer S, et al. The phagosome proteome: insight into phagosome functions. J Cell Biol. 2001;152:165-160.
31. Desjardins M. ER-mediated phagocytosis: a new membrane for new functions. Nat Rev Immunol. 2003;3:280-291.
32. Link AJ, Eng J, Schieltz DM, et al. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol. 1999;17:676-682.
33. Washbum MP, Wolters D, Yates JR 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol. 2001;19:242-247.
34. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422:196-207.
35. Rees DC, Rochette J, Schofield C, et al. A novel silent posttranslational mechanism converts methionine to aspartate in hemoglobin Bristol (beta 67[E11] Val-Met → Asp). Blood. 1996;66:341-348.
36. Troxler H, Neuheiser F, Kleinert P, et al. Detection of a novel variant human hemoglobin by electrospray ionization mass spectrometry. Biochem Biophys Res Commun. 2002;292:1044-1047.
37. Clark RE, Dodi IA, Hill SC, et al. Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood. 2001;98:2887-2893.
38. Lasonder E, Ishihama Y, Andersen JS, et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature. 2002; 419:537-542.
39. Demirev PA, Feldman AB, Kongkasuriyachai D, Scholl P, Sullivan D Jr, Kumar N. Detection of malaria parasites in blood by laser desorption mass spectrometry. Anal Chem. 2002;74:3262-3266.
40. Smith DL, Evans CA, Pierce A, Gaskell SJ, Whetton AD. Changes in the proteome associated with the action of bcr-abl tyrosine kinase are not related to transcriptional regulation. Mol Cell Proteomics. 2002;1:676-664.
41. Issaq HJ, Veenstra TD, Conrads TP, Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun. 2002;292:567-592.
42. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359:572-577.
43. Petricoin EF 3rd, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst. 2002;94:1576-1576.
44. Zhukov TA, Johanson RA, Cantor AB, Clark RA, Tockman MS. Discovery of distinct protein profiles specific for lung tumors and premalignant lung lesions by SELDI mass spectrometry. Lung Cancer. 2003;40:267-279.
45. Dayal B, Ertel NH. ProteinChip technology: a new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease. J Proteome Res. 2002;1:375-380.
46. Caprioli RM, Farmer TB, Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem. 1997;69:4751-4760.
47. Yanagisawa K, Shyr Y, Xu BJ, et al. Proteornic patterns of tumour subsets in non-small-cell lung cancer. Lancet. 2003;362:433-439.
48. Hunt DF, Yates JR 3rd, Shabanowitz J, Winston S, Hauer CR. Protein sequencing by tandem mass spectrometry. Proc Natl Acad Sci U S A. 1986;83:6233-6237.
49. Fields CG, VanDrisse VL, Fields GB. Edman degradation sequence analysis of resin-bound peptides synthesized by 9-fluorenylmethoxycarbonyl chemistry. Pept Res. 1993;6:39-47.
50. Qin J, Chait BT. Matrix-assisted laser desorption ion trap mass spectrometry: efficient isolation and effective fragmentation of peptide ions. Anal Chem. 1996;66:2106-2112.
51. Medzihradszky KF, Campbell JM, Baldwin MA, et al. The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer. Anal Chem. 2000;72:552-558.
52. Loboda AV, Krutchinsky AN, Bromirski M, Ens W, Standing KG. A tandem quadrupole/time-of-flight mass spectrometer with a matrix-assisted laser desorption/ionization source: design and performance. Rapid Commun Mass Spectrom. 2000; 14:1047-1057.
53. Mann M, Hoirup P, Roepstorff P. Use of mass spectrometric molecular weight information to identify proteins in sequence databases. Biol Mass Spectrom. 1993;22:338-345.
54. Yates JR 3rd, Speicher S, Griffin PR, Hunkapiller T. Peptide mass maps: a highly informative approach to protein identification. Anal Biochem. 1993;214:397-408.
55. Eng JK, McCormack AL, Yates JR 3rd. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom. 1994;5:976-989.
56. Fenyo D, Qin J, Chait BT. Protein identification using mass spectrometric information. Electrophoresis. 1998;19:998-1005.
57. van der Rest G, He F, Emmett MR, Marshall AG, Gaskell SJ. Gas-phase cleavage of PTC-derivatized electrosprayed tryptic peptides in an FT-ICR trapped-ion cell: mass-based protein identification without liquid chromatographic separation. J Am Soc Mass Spectrom. 2001;12:288-295.
58. Brancia FL, Oliver SG, Gaskell SJ. Improved matrix-assisted laser desorption/ionization mass spectrometric analysis of tryptic hydrolysates of proteins following guanidination of lysine-containing peptides. Rapid Commun Mass Spectrom. 2000;14:2070-2073.
59. Steen H, Pandey A. Proteomics goes quantitative: measuring protein abundance. Trends Biotechnol. 2002;20:361-364.
60. Han DK, Eng J, Zhou H, Aebersold R. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat Biotechnol. 2001;19:946-951.
61. Marshall AG, Senko MW, Li W, et al. Protein molecular mass to 1 Da by 13C 15N double depletion and FT-ICR mass spectrometry. J Am Chem Soc. 1997;119:433-434.
62. Pratt JM, Robertson DH, Gaskell SJ, et al. Stable isotope labelling in vivo as an aid to protein identification in peptide mass fingerprinting. Proteomics. 2002;2:157-163.
63. Cristea IM. Proteome changes during early stages of cell injury [doctoral dissertation]. Manchester, United Kingdom: University of Manchester Institute of Science and Technology. 2002.
64. Bonenfant D, Schmeizie T, Jacinto E, et al. Quantitation of changes in protein phosphorylation: a simple method based on stable isotope labeling and mass spectrometry. Proc Natl Acad Sci U S A. 2003;100:880-885.
65. Griffin TJ, Gygi SP, Rist B, et al. Quantitative proteomic analysis using a MALDI quadrupole time-of-flight mass spectrometer. Anal Chem. 2001;73: 978-988.
66. Patton WF, Schulenberg B, Steinberg TH. Two-dimensional gel electrophoresis; better than a poke in the ICAT? Curr Opin Biotechnol. 2002;13: 321-328.
67. Shilo Y, Donohoe S, Yi EC, Goodlett DR, Aebersold R, Eisenman RN. Quantitative proteomic analysis of Myc oncoprotein function. EMBO J. 2002;21:5088-5096.
68. Barnidge DR, Dratz EA, Martin T, Bonilla LE, Moran LB, Lindall A. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal Chem. 2003;75:445-451.
69. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A. 2003;100:6940-6945.
70. Lamond AI, Mann M. Cell biology and the genome projects - a concerted strategy for characterizing multiprotein complexes by using mass spectrometry. Trends Cell Biol. 1998;7:135-174.
71. Zhu H, Bilgin M, Bangham R, et al. Global analysis of protein activities using proteome chips. Science. 2001;293:2101-2105.
72. Pawiak M, Schick E, Bopp MA, Schneider MJ, Oroszlan P, Ehrat M. Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics. 2002;2:383-393.
73. Mitchell P. A perspective on protein microarrays. Nat Biotechnol. 2002;20:225-229.
74. Taussig MJ. Protein arrays: issues to be addressed: The chairperson's introduction to the session peptide and protein chips from the ESF workshop Proteomics: focus on protein interactions. Comp Functional Genomics. 2001;2:298-300.
75. MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science. 2000;289:1760-1783.
76. Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res. 2001;81:4483-4489.
77. Hebestreit HF. Proteomics: an holistic analysis of nature's proteins. Curr Opin Pharmacol. 2001;1: 513-520.
78. Adam GC, Sorensen EJ, Crevatt BF. Chemical strategies for functional proteomics. Mol Cell Proteomics. 2002;1:781-790.
79. Brody EN, Willis MC, Smith JD, Jayasena S, Zichi D, Gold L. The use of aptamers in large arrays for molecular diagnostics. Mol Diagn. 1999;4:381-388.
80. Tasset DM, Kubik MF, Steiner W. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J Mol Biol. 1997;272:688-698.
81. Krishna RG, Wold F. Post-translational modification of proteins. Adv Enzymol Relat Areas Mol Biol. 1993;67:265-298.
82. Qin J, Chait BT. Identification and characterization of posttranslational modifications of proteins by MALDI ion trap mass spectrometry. Anal Chem. 1997;69:4002-4009.
83. Zhou H, Watts JD, Aebersold R. A systematic approach to the analysis of protein phosphorylation. Nat Biotechnol. 2001;19:375-378.
84. McLachlin DT, Chait BT. Analysis of phosphorylated proteins and peptides by mass spectrometry. Curr Opin Chem Biol. 2001;5:591-602.
85. Steen H, Fernandez M, Ghaffari S, Pandey A, Mann M. Phosphotyrosine mapping in Bcr/Abl oncoprotein using phosphotyrosine-specific immonium ion scanning. Mol Cell Proteomics. 2003; 2:138-145.
86. Salomon AR, Ficarro SB, Brill LM, et al. Profiling of tyrosine phosphorylation pathways in human calls using mass spectrometry. Proc Natl Acad Sci U S A. 2003;100:443-448.
87. Taylor CF, Paton NW, Garwood KL, et al. A systematic approach to modeling, capturing, and disseminating proteomics experimental data. Nat Biotechnol. 2003;21:247-254.
88. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001;29:365-371.
89. Walker J, Flower D, Rigley K. Microarrays in hematology. Curr Opin Hematol. 2002;9:23-29.
90. Steiner S, Witzmann FA. Proteomics: applications and opportunities in preclinical drug development. Electrophoresis. 2000;21:2099-2104.
91. Shaw J, Rowlinson R, Nickson J, et al. Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics. 2003;3:1181-1195.
92. Hillenkamp F, Karas M. Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser desorption/ionization. Methods Enzymol. 1990;193:280-295.
93. Stensballe A, Jensen ON, Olsen JV, Haselmann KF, Zubarev RA. Electron capture dissociation of singly and multiply phosphorylated peptides. Rapid Commun Mass Spectrom. 2000;14:1793-1800.
94. Oda Y, Nagasu T, Chait BT. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat Biotechnol. 2001;19: 379-382.
95. Martinovic S, Veenstra TD, Anderson GA, Pasa-Tolic L, Smith RD. Selective incorporation of isotopically labeled amino acids for identification of intact proteins on a proteome-wide level. J Mass Spectrom. 2002;37:99-107.
96. Zhang R, Sioma CS, Wang S, Regnier FE. Fractionation of isotopically labeled peptides in quantitative proteomics. Anal Chem. 2001;73:5142-5149.
97. 13C-isotope-coded affinity tag and multidimensional chromatography. Mol Cell Proteomics. 2003;2:299-314.
98. Mann M, Ong SE, Gronborg M, Steen H, Jensen ON, Pandey A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 2002;20: 261-268.
99. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1996; 68:850-858.